Daiichi Sankyo’s allegations false: Malvinder Singh

May 23, 2013 01:21 pm | Updated November 16, 2021 10:21 pm IST - Mumbai

Former promoters of Ranbaxy, on Thursday, rebutted the current Japanese owner’s allegations of hiding information on U.S. probe into drug adulteration, saying they did not misrepresent any facts or falsify any data.

Malvinder Mohan Singh, the former promoter of Ranbaxy, said he was shocked at allegations made by Daiichi Sankyo and asserted the Indian promoters never concealed any fact at the time of selling 34.82 per cent stake to the Japanese firm for about Rs.10,000 crore.

“We strongly deny that the Singh family falsified any data. There was no concealment of facts,” Mr. Singh, who is also the Executive Chairman of Fortis Healthcare, told PTI here.

Daiichi had yesterday threatened to sue Singhs for allegedly concealing and misrepresenting critical information about U.S. investigation into sale of adulterated drugs.

Top News Today


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.